3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
2
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
7
Hereditary Sensory and Autonomic Neuropathies
3
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Rectal Neoplasms
1
Neoplasms
1
Hyperglycemia
1
Exanthema
1
Advanced or Metastatic ER+ Breast Cancer
1
Advanced Breast Cancer
1
Interventions
volagidemab
2
dapagliflozin
1
Metformin
1
Insulin Glargine
1
Insulin Aspart
1
Fulvestrant
1
Alpelisib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Hyperglycemia
×
Alpelisib
×
Clear all
NCT04899349
2024-10-09
EPIK-B4
Novartis
Phase 2
Terminated
2 enrolled
8 charts